These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 17867594

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
    Williams MD, Roberts D, Blumenschein GR, Temam S, Kies MS, Rosenthal DI, Weber RS, El-Naggar AK.
    Am J Surg Pathol; 2007 Nov; 31(11):1645-52. PubMed ID: 18059220
    [Abstract] [Full Text] [Related]

  • 7. Sarcomatoid variant of salivary duct carcinoma: clinicopathologic and immunohistochemical study of eight cases with review of the literature.
    Nagao T, Gaffey TA, Serizawa H, Iwaya K, Watanabe A, Yoshida T, Yamazaki K, Sageshima M, Lewis JE.
    Am J Clin Pathol; 2004 Aug; 122(2):222-31. PubMed ID: 15323139
    [Abstract] [Full Text] [Related]

  • 8. Salivary duct carcinoma in situ of the parotid gland.
    Simpson RH, Desai S, Di Palma S.
    Histopathology; 2008 Oct; 53(4):416-25. PubMed ID: 18983607
    [Abstract] [Full Text] [Related]

  • 9. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
    Di Palma S, Simpson RH, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho JS.
    Histopathology; 2012 Oct; 61(4):629-43. PubMed ID: 22882517
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Three new cases of salivary duct carcinoma in the palate: a radiologic investigation and review of the literature.
    Huh KH, Heo MS, Lee SS, Choi SC.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2003 Jun; 95(6):752-60. PubMed ID: 12789160
    [Abstract] [Full Text] [Related]

  • 12. Androgen receptor immunohistochemistry in salivary duct carcinoma: a retrospective study of 188 cases focusing on tumoral heterogeneity and temporal concordance.
    Xu B, Dogan S, Haroon Al Rasheed MR, Ghossein R, Katabi N.
    Hum Pathol; 2019 Nov; 93():30-36. PubMed ID: 31430492
    [Abstract] [Full Text] [Related]

  • 13. Relative paucity of gross genetic alterations in myoepitheliomas and myoepithelial carcinomas of salivary glands.
    Hungermann D, Roeser K, Buerger H, Jäkel T, Löning T, Herbst H.
    J Pathol; 2002 Dec; 198(4):487-94. PubMed ID: 12434418
    [Abstract] [Full Text] [Related]

  • 14. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature.
    Fan CY, Wang J, Barnes EL.
    Am J Surg Pathol; 2000 Apr; 24(4):579-86. PubMed ID: 10757407
    [Abstract] [Full Text] [Related]

  • 15. [About the prognostic value of Her-2 gene-amplification and cell-proliferation in salivary duct carcinoma of the major salivary glands - a pilot-study].
    Jaehne M, Jäkel KT, Röser K, Ussmüller J, Löning T.
    Laryngorhinootologie; 2001 Sep; 80(9):525-9. PubMed ID: 11555785
    [Abstract] [Full Text] [Related]

  • 16. An analysis of PLAG1 and HMGA2 rearrangements in salivary duct carcinoma and examination of the role of precursor lesions.
    Bahrami A, Perez-Ordonez B, Dalton JD, Weinreb I.
    Histopathology; 2013 Aug; 63(2):250-62. PubMed ID: 23738717
    [Abstract] [Full Text] [Related]

  • 17. Salivary duct carcinoma of the larynx: report of a rare case.
    Goel MM, Agrawal SP, Srivastava AN.
    Ear Nose Throat J; 2003 May; 82(5):371-3. PubMed ID: 12789763
    [Abstract] [Full Text] [Related]

  • 18. Molecular characterization of apocrine salivary duct carcinoma.
    Chiosea SI, Williams L, Griffith CC, Thompson LD, Weinreb I, Bauman JE, Luvison A, Roy S, Seethala RR, Nikiforova MN.
    Am J Surg Pathol; 2015 Jun; 39(6):744-52. PubMed ID: 25723113
    [Abstract] [Full Text] [Related]

  • 19. Biomarker immunoprofile and molecular characteristics in salivary duct carcinoma: clinicopathological and prognostic implications.
    Santana T, Pavel A, Martinek P, Steiner P, Grossmann P, Baněčková M, Skálová A.
    Hum Pathol; 2019 Nov; 93():37-47. PubMed ID: 31437521
    [Abstract] [Full Text] [Related]

  • 20. Cytokeratin KRT8/18 expression differentiates distinct subtypes of grade 3 invasive ductal carcinoma of the breast.
    Walker LC, Harris GC, Holloway AJ, McKenzie GW, Wells JE, Robinson BA, Morris CM.
    Cancer Genet Cytogenet; 2007 Oct 15; 178(2):94-103. PubMed ID: 17954264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.